Microbeam X-ray fluorescence mapping of Cu and Fe in human prostatic carcinoma cell lines using synchrotron radiation

Karolynne José Rocha; Roberta Gama Leitão; Eliane Oliveira Barros; Maria Aparecida Oliveira; Catarine Gondim Canellas; Marcelino José Anjos; Luiz Eurico Nasciutti; Ricardo Tadeu Lopes

doi:10.15392/bjrs.v7i2A.608

Microbeam X-ray fluorescence mapping of Cu and Fe in human prostatic carcinoma cell lines using synchrotron radiation

Authors

Karolynne José Rocha Nuclear Instrumentation Laboratory/Federal University of Rio de Janeiro
Roberta Gama Leitão Physics Institute/Stated University of Rio de Janeiro
Eliane Oliveira Barros Institute of Biomedical Sciences/Federal University of Rio de Janeiro
Maria Aparecida Oliveira Institute of Biomedical Sciences/Federal University of Rio de Janeiro
Catarine Gondim Canellas Physics Institute/Stated University of Rio de Janeiro
Marcelino José Anjos Physics Institute/Stated University of Rio de Janeiro
Luiz Eurico Nasciutti Institute of Biomedical Sciences/Federal University of Rio de Janeiro
Ricardo Tadeu Lopes Nuclear Instrumentation Laboratory/Federal University of Rio de Janeiro

DOI:

https://doi.org/10.15392/bjrs.v7i2A.608

Keywords:

X-Ray, microfluorescence, cancer

Abstract

Cancer is a worldwide public health problem and prostate cancer continues to be one of the most common fatal cancers in men. Copper plays an important role in the aetiology and growth of tumours however, whether intratumoral copper is actually elevated in prostate cancer patients has not been established. Iron, an important trace element, plays a vital function in oxygen metabolism, oxygen uptake, and electron transport in mitochondria, energy metabolism, muscle function, and hematopoiesis. The X-ray microfluorescence technique (μXRF) is a rapid and non-destructive method of elemental analysis that provides useful elemental information about samples without causing damage or requiring extra sample preparations. This study investigated the behavior of cells in spheroids of human prostate cells, tumour cell line (DU145) and normal cell line (RWPE-1), after supplementation with zinc chloride by 24 hours using synchrotron X-ray microfluorescence (μSRXRF). The measurements were performed with a standard geometry of 45º of incidence, excited by a white beam using a pixel of 25 μm and a time of 300 ms/pixel at the XRF beamline at the Synchrotron Light.

Downloads

Download data is not yet available.

References

Web Site

National Cancer Institute José Alencar Gomes da Silva. Estimate 2016: Cancer Incidence in Bra-zil. 2016. Available at: http://www.inca.gov.br/wcm/dncc/2015/estimativa-2016.pdf>.

Journal

GOUGH, Mallory et al. The E1 copper binding domain of full-length amyloid precursor protein mitigates copper-induced growth inhibition in brain metastatic prostate cancer DU145 cells. Bio-chemical And Biophysical Research Communications, v. 453, p. 741-747, 2014.

Journal

DENOYER, Delphine et al. Heterogeneous copper concentrations in cancerous human prostate tis-sues. The Prostate, v. 75, p. 1510-1517, 2015.

Journal

DENOYER, Delphine et al. Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution. Oncotarget, v. 7, p. 37064-37080, 2016.

Journal

LUDWIG, Heinz et al. Iron metabolism and iron supplementation in cancer patients. Wiener Klinische Wochenschrift, v. 127, p. 907-919, 2015.

Journal

RODRIGO, Miguel Angel Merlos et al. Zinc and metallothionen in prostate cancer: A review. Journal Of Metallomics And Nanotechnologies, v. 2, p. 58-63, 2015.

Journal

COSTELLO, Leslie C.; FRANKLIN, Renty B. A comprehensive review of the role of zinc in nor-mal prostate function and metabolism; and its implications in prostate cancer. Archives Of Bio-chemistry And Biophysics, v. 611, p. 100-112, 2016.

Journal

JOHNSON, Leslie A. et al. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods, v. 52, p. 316-321, 2010.

Journal

LANKOSZ, M. et al. Research in quantitative microscopic X-ray fluorescence analysis. Spectrochimica Acta Part B: Atomic Spectroscopy, v. 59, p. 1517-1521, 2004.

Journal

RAK, Margaret et al. X-ray microfluorescence (μXRF) imaging of Aspergillus nidulans cell wall mutants reveals biochemical changes due to gene deletions. Analytical And Bioanalytical Chem-istry, v. 406, p. 2809-2816, 2014.

Journal

ROCHA, K.M.J et al. H Zinc distribution in human prostate carcinoma cell line using synchrotron X-ray microfluorescence. X-Ray Spectrometry, v. 46, p. 403-411, 2017.

Journal

XUE, Dong et al. Decreased expression of ferroportin in prostate cancer. Oncology Letters, v. 10, p. 913-916, 2015.

Downloads

Published

2019-02-19

Issue

Vol. 7 No. 2A (Suppl.) (2019): ENAN 2017

Section

Articles

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

How to Cite

Microbeam X-ray fluorescence mapping of Cu and Fe in human prostatic carcinoma cell lines using synchrotron radiation. Brazilian Journal of Radiation Sciences, Rio de Janeiro, Brazil, v. 7, n. 2A (Suppl.), 2019. DOI: 10.15392/bjrs.v7i2A.608. Disponível em: https://bjrs.org.br/revista/index.php/REVISTA/article/view/608. Acesso em: 22 dec. 2024.